We are live on ! Find out more
PCM

Pavaki Capital Management Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+12.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow %
54.05%
Top 10 Hldgs %
57.32%
Holding
131
New
131
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MIST icon
Milestone Pharmaceuticals
MIST
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$13.2M
3
SPRY icon
ARS Pharmaceuticals
SPRY
+$11.4M
4
B
Barrick Mining
B
+$7.28M
5
DIS icon
Walt Disney
DIS
+$6.72M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 44.5%
2 Healthcare 29.54%
3 Materials 10.85%
4 Communication Services 4.97%
5 Technology 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLNG icon
126
Dynagas LNG Partners
DLNG
$138M
$113K 0.04%
+30,000
New +$110K
WPP icon
127
WPP
WPP
$5.45B
$112K 0.04%
+5,000
New +$108K
AKO.B icon
128
Embotelladora Andina Series B
AKO.B
$4.8B
$112K 0.04%
+4,000
New +$104K
GGB icon
129
Gerdau
GGB
$9.1B
$93K 0.04%
+25,200
New +$88.1K
BRK.B icon
130
Berkshire Hathaway Class B
BRK.B
$1.08T
$50.3K 0.02%
+100
New +$49.8K
SPRY icon
131
CALL
ARS Pharmaceuticals
SPRY
$438M
$17.5K 0.01%
+1,500
New +$14.6K
2 3 4 5
6

Similar funds

OCM
Ogborne Capital Management San Francisco, California $287M AUM 14.05% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
MC
Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
ORC
O'Rourke & Company Boston, Massachusetts $287M AUM 23.01% 1-Year Est. Return
MPAM
Murphy Pohlad Asset Management Eden Prairie, Minnesota $287M AUM 38.81% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

Pavaki Capital Management's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for Pavaki Capital Management, which disclosed 131 positions worth $255M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, followed by Healthcare and Materials.

  • Pavaki Capital Management's largest Q4 2025 buy was Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
  • Pavaki Capital Management's ten largest holdings make up 57% of its $255M portfolio in Q4 2025.
  • Pavaki Capital Management disclosed 131 positions in Q4 2025, its first 13F filing on record.

Based on Pavaki Capital Management's 13F filing for Q4 2025, filed 7 Aug 2026.